Clinical investigators worldwide are beginning to recruit 1,200 patients with relapsing multiple sclerosis for a study assessing the effectiveness of two different doses of…
A recent report by Marie Curie fellows organization suggests that those suffering from neurological conditions such as multiple sclerosis are missing out…
The Association of British Neurologists (ABN) recently published new guidelines for how Disease Modifying Therapies (DMTs) for relapsing remitting multiple sclerosis…
A recent study suggests that in the future multiple sclerosis patients could benefit from treatments intended to boost their brain…
An international group of researchers from the Center for Brain Research at the MedUni Vienna have published a…
2014 was a year of major progress in research for treating and curing multiple sclerosis (MS), according to the…
Novartis International recently provided an update on its fingolimod Phase III trial evaluating the…
Ipsen Biopharmaceuticals, Inc announced that the United States Food and Drug Administration (FDA) has agreed to review…
The Treat Me Right campaign from the MS Society in the UK was recently shortlisted for this year’s…
Highmark Blue Cross Blue Shield is trying to assess the possibility of predicting good and bad days for people…
Researchers from UC San Francisco, the Broad Institute of MIT and Harvard, and Yale School of Medicine recently…
Multiple Sclerosis information resource MSology.com has announced the launch of MS Radio, an exclusive MS-focused…
StatRad is a technology leader in radiology and HealthCare Journey a…
Get regular updates to your inbox.
